Search Results for: mcur.c

Today Maddy speaks with the president & CEO of Mindcure (MCUR.C), Kelsey Ramsden. Kelsey breaks down the burgeoning therapeutic world of psychedelics and outlines Mindcure’s uniquely comprehensive approach of…
Another busy week in the psychedelic sector, with many smaller companies not always covered here at Equity Guru making news. Let’s start with the biggest players though. Mind Medicine…
Oura Rings I have an Oura Ring, I bought it a few years back to try and better understand my sleeping patterns. After a few months of use, I…
Mind Cure Health (MCUR.C) announced they have launched the second stage of manufacturing pharmaceutical grade ibogaine to be used in clinical research. MINDCURE will be assessing the quality of…
Mind Cure Health (MCUR.C) announced the development of two proprietary ketamine-enhanced protocols specifically for pain management and another for depression, according to a press release.   Depression is basically…
Multiple pivots Mind Cure (MCUR.C) began as a mushroom nootropic deal that has since shifted to ibogaine production and the development digital platforms. The company has been able to…
Mind Cure (MCUR.C), a mental health and wellness company based in British Columbia, have announced today that it has partnered with SOMA Breath to add breathing techniques to iSTRYM,…
Mind Cure (MCUR.C), a leader in advanced proprietary technology for psychedelic therapy, has provided updates regarding its financial position, near-term revenue strategy, and a timeline for iSTRYM’s market launch….
Mind Cure Health (MCUR.C) has entered into a partnership and licensing deal with SOMA Breath Inc. “We think it is important to give individuals options in building their mental…
Mind Cure (MCUR.C) has partnered with Lucid Inc. to design custom psychedelic music experiences for the Company’s iSTRYM technology. “We are building first-of-its-kind functionality by pairing AI-driven music scapes…